Chenyu Huang, M.D., Ph.D.
China
Associate professor, Beijing Tsinghua Changgung Hospital, Tsinghua University
EXPERTISE
Clinical management of pathological scarring, e.g. keloids & hypertrophic scars.
Fundamental explorations in keloid etiology, in particular the mechanobiology mechanisms.
Proposing and applying mechanotherapy in scars, targeting at preventing or reducing scars by mechanical means at molecular, cellular, or tissue levels.
Translational research based on scar mechanobiology and mechanotherapy
With >55 professional journal article publications focusing on skin fibrosis since 2010
EDUCATION
2004/9-2007/7 Peking Union Medical College & Tsinghua University, Ph.D.
1999/9-2002/7 Institute of Traumatology and Orthopedics & Peking University, M.Sc.
1994/9-1999/7 Capital University of Medical Sciences, M.D.
PROFESSIONAL EXPERIENCE
2014/8 till now Beijing Tsinghua Changgung Hospital, Tsinghua University, Associate professor
2013/1-2013/12 Brigham and Women’s Hospital, Harvard Medical School, Postdoc
2009/9-2011/8 Nippon Medical School, Visiting scholar
PUBLICATIONS (selected)
(1) Mechanotherapy: revisiting physical therapy and recruiting mechanobiology for a new era in medicine. Trends Mol Med. 2013;19:555-64.
(2) TGase-Enhanced Microtissue Assembly in 3D-Printed-Template-Scaffold (3D-MAPS) for Large Tissue Defect Reparation. Adv Healthc Mater. 2020;9(18):e2000531.
(3) Endothelial dysfunction and mechanobiology in pathological cutaneous scarring: lessons learned from soft tissue fibrosis. Br J Dermatol. 2017;177:1248-1255.
(4) Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression. FASEB J. 2021;35(7):e21705.
(5) Mechanosignaling pathways in cutaneous scarring. Arch Dermatol Res. 2012;304:589-97.
Clinical management of pathological scarring, e.g. keloids & hypertrophic scars.
Fundamental explorations in keloid etiology, in particular the mechanobiology mechanisms.
Proposing and applying mechanotherapy in scars, targeting at preventing or reducing scars by mechanical means at molecular, cellular, or tissue levels.
Translational research based on scar mechanobiology and mechanotherapy
With >55 professional journal article publications focusing on skin fibrosis since 2010
EDUCATION
2004/9-2007/7 Peking Union Medical College & Tsinghua University, Ph.D.
1999/9-2002/7 Institute of Traumatology and Orthopedics & Peking University, M.Sc.
1994/9-1999/7 Capital University of Medical Sciences, M.D.
PROFESSIONAL EXPERIENCE
2014/8 till now Beijing Tsinghua Changgung Hospital, Tsinghua University, Associate professor
2013/1-2013/12 Brigham and Women’s Hospital, Harvard Medical School, Postdoc
2009/9-2011/8 Nippon Medical School, Visiting scholar
PUBLICATIONS (selected)
(1) Mechanotherapy: revisiting physical therapy and recruiting mechanobiology for a new era in medicine. Trends Mol Med. 2013;19:555-64.
(2) TGase-Enhanced Microtissue Assembly in 3D-Printed-Template-Scaffold (3D-MAPS) for Large Tissue Defect Reparation. Adv Healthc Mater. 2020;9(18):e2000531.
(3) Endothelial dysfunction and mechanobiology in pathological cutaneous scarring: lessons learned from soft tissue fibrosis. Br J Dermatol. 2017;177:1248-1255.
(4) Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression. FASEB J. 2021;35(7):e21705.
(5) Mechanosignaling pathways in cutaneous scarring. Arch Dermatol Res. 2012;304:589-97.